UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$25.3B |
| 2 |
Bank of America
BAC
|
+$1.96B |
| 3 |
Applied Materials
AMAT
|
+$1.43B |
| 4 |
NetEase
NTES
|
+$1.18B |
| 5 |
Union Pacific
UNP
|
+$870M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$7.17B |
| 2 |
Apple
AAPL
|
+$3.39B |
| 3 |
UBS Group
UBS
|
+$2.73B |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$2.53B |
| 5 |
Meta Platforms (Facebook)
META
|
+$2.04B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 37.88% |
| 2 | Financials | 12.37% |
| 3 | Consumer Discretionary | 10.53% |
| 4 | Healthcare | 9.66% |
| 5 | Communication Services | 9.36% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
576
Qualys
QLYS
$6.35B
| $58.6M | 0.01% |
442,711
-56,119
| -11% | -$7.61M |
|
577
NuScale Power
SMR
$4.03B
| $58.6M | 0.01% |
1,626,879
-350,187
| -18% | -$14M |
|
578
Hannon Armstrong Sustainable Infrastructure Capital
HASI
$5.2B
| $58.4M | 0.01% |
1,903,532
+1,766,093
| +1,285% | +$48.7M |
|
579
BioMarin Pharmaceuticals
BMRN
$12.4B
| $58.2M | 0.01% |
1,074,173
-245,619
| -19% | -$14M |
|
580
Entegris
ENTG
$23.2B
| $58.1M | 0.01% |
628,317
-120,379
| -16% | -$10.2M |
|
|
IPG
581
DELISTED
Interpublic Group of Companies
IPG
| $58M | 0.01% |
2,079,089
-857,449
| -29% | -$22.1M |
|
582
Jones Lang LaSalle
JLL
$16.7B
| $58M | 0.01% |
194,308
-74,742
| -28% | -$21.4M |
|
583
Guidewire Software
GWRE
$14.2B
| $57.8M | 0.01% |
251,371
-129,233
| -34% | -$29.4M |
|
584
Fortune Brands Innovations
FBIN
$6.06B
| $57.5M | 0.01% |
1,076,343
-784
| -0.1% | -$44.2K |
|
585
Solventum
SOLV
$14.1B
| $56.6M | 0.01% |
775,152
-286,498
| -27% | -$21M |
|
586
FIVE9
FIVN
$2.54B
| $56.2M | 0.01% |
2,320,745
+217,227
| +10% | +$5.74M |
|
|
KLAR
587
Klarna Group
KLAR
$7.52B
| $55.8M | 0.01% |
+1,523,689
| New | +$65.2M |
|
588
SentinelOne
S
$7.34B
| $55.3M | 0.01% |
3,142,649
-334,024
| -10% | -$5.99M |
|
589
Bentley Systems
BSY
$10.6B
| $54.9M | 0.01% |
1,066,152
-81,399
| -7% | -$4.46M |
|
590
News Corp Class A
NWSA
$15.4B
| $54.6M | 0.01% |
1,776,561
-453,179
| -20% | -$13.4M |
|
591
MYR Group
MYRG
$5.25B
| $54.2M | 0.01% |
260,632
-31,658
| -11% | -$5.91M |
|
592
Privia Health
PRVA
$2.87B
| $53.9M | 0.01% |
2,165,355
+55,944
| +3% | +$1.2M |
|
593
Hormel Foods
HRL
$13.8B
| $53.2M | 0.01% |
2,152,290
-650,355
| -23% | -$18M |
|
594
NNN REIT
NNN
$8.99B
| $53.1M | 0.01% |
1,247,323
+1,037,595
| +495% | +$44.1M |
|
595
Watsco Inc
WSO
$13.6B
| $52.2M | 0.01% |
129,044
-31,345
| -20% | -$13.4M |
|
596
Itron
ITRI
$4.54B
| $52M | 0.01% |
417,764
-176,697
| -30% | -$22.5M |
|
597
Old Republic International
ORI
$10.4B
| $51.4M | 0.01% |
1,209,480
-447,243
| -27% | -$17.3M |
|
598
Universal Health Services
UHS
$10.5B
| $51.2M | 0.01% |
250,282
-52,707
| -17% | -$9.48M |
|
599
Agree Realty
ADC
$9.41B
| $50.8M | 0.01% |
714,772
+601,689
| +532% | +$43.6M |
|
600
Moderna
MRNA
$23.6B
| $50.7M | 0.01% |
1,960,968
-1,062,259
| -35% | -$29.6M |
|
Similar funds
UBS AM's Q3 2025 Portfolio in Review
As of Q3 2025, UBS AM held 2,672 positions worth $461B, down 6.8% from $494B the previous quarter. Its ten largest holdings account for 35% of the portfolio.
UBS AM withdrew a net $68.7B in Q3 2025, closing 403 positions and reducing 2,008 holdings. Its most notable exit was Pinduoduo, an estimated $967M position sold in full.
By sector, the portfolio is most concentrated in Technology at 38% of assets, up from 32% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, UBS AM opened a new position in Vanguard Dividend Appreciation ETF worth $135M.
- UBS AM's largest Q3 2025 buy was Vanguard Dividend Appreciation ETF: 624,303 shares worth $135M.
- UBS AM added most to Microsoft in Q3 2025, an estimated $25.3B increase.
- UBS AM's biggest Q3 2025 reduction was NVIDIA, cutting an estimated $7.17B.
- UBS AM fully exited Pinduoduo in Q3 2025, selling an estimated $967M.
- UBS AM's ten largest holdings make up 35% of its $461B portfolio in Q3 2025.
- UBS AM opened 67 new positions and closed 403 in Q3 2025.
- UBS AM's portfolio value fell 6.8% quarter-over-quarter to $461B.
Based on UBS AM's 13F filing for Q3 2025, filed 14 Nov 2025.